Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-11 Option Award |
2025-02-13 6:07 pm |
N/A N/A |
REVELATION BIOSCIENCES INC. | REVB | Rolke James Chief Executive Officer |
30,095 | $3.87 | 30,179 (Direct) |
View |
| 2023-02-25 Option Award |
2023-02-28 4:08 pm |
N/A 2032-02-25 |
REVELATION BIOSCIENCES INC. | REVB | Rolke James Chief Executive Officer |
2,542 | $0 | 0 (Direct) |
View |
Ownership |
2022-01-20 6:03 pm |
N/A N/A |
REVELATION BIOSCIENCES INC. | REVB | Rolke James Chief Executive Officer |
0 | $0 | 757,064 (Direct) |
View |
| 2020-05-29 Option Award |
2020-06-02 4:02 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
205 | $4.01 | 81,976 (Direct) |
View |
| 2020-05-29 Option Award |
2020-06-02 4:02 pm |
N/A 2030-05-29 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
205 | $0 | 81,976 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-19 4:05 pm |
N/A 2030-05-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
140 | $0 | 81,706 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-19 4:05 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
140 | $5.86 | 81,706 (Direct) |
View |
| 2020-04-30 Option Award |
2020-05-04 4:09 pm |
N/A 2030-04-30 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
133 | $0 | 81,559 (Direct) |
View |
| 2020-04-30 Option Award |
2020-05-04 4:09 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
133 | $6.17 | 81,559 (Direct) |
View |